USTRx Act
introducedSign in to watch / set alerts
TQL analysis
D58
58 / 90 · methodology full_text_v3
The USTRx Act aims to address international trade practices that exploit U.S. pharmaceutical innovation by establishing a Chief Pharmaceutical Trade Negotiator and requiring annual reports on high-income countries' trade practices. It mandates responses to adverse actions by these countries but lacks detailed fiscal analysis and clear accountability measures.
Structural flags
⚑ Spends without a pay-for — authorizes new spending with no stated offset or pay-for
Legislative structure
Criterion breakdown8 criteria · max 90
Advanced Full criterion breakdown
The letter, score, and explanation above are free. The point-by-point breakdown of all eight scored criteria — with each criterion's value and how it moved the grade — is a Quiet Ledger research capability.
Access options →Actions (2)
| Date | Time | Action |
|---|---|---|
| 2026-08-05 | — | Read twice and referred to the Committee on Finance. |
| 2026-08-05 | — | Introduced in Senate |
Provenance
- Methodology
- full_text_v3
- Calculated
- 2026-09-18 17:02:56.368+00
- Source version
- 2026-08-05
- Assessments
- —
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.